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weeks, with improvement in hepatic function. Although the renal
function improved, the creatinine clearance was poor. The patient
underwent intermittent dialysis through side access ports on the right
VAD tubing. Assessment of cardiac recovery was performed with
serial echocardiograms, demonstrating persistent severe biventricular
failure. The decision was made to list the patient for heart and kidney
transplantation. On November 12, 2001, the patient underwent suc-
cessful double organ transplantation. The postoperative course was
uneventful, with no major complications. The patient was discharged
to a rehabilitation center for several months of recovery. He was then
discharged to home and remains alive and well more than 1 year later.
Discussion
The management of postinfarction VSD remains a therapeutic
challenge. Surgical mortality remains high, and initial repairs may
be plagued by persistent heart failure, VSD recurrence, and ar-
rhythmia.2 As such, this entity continues to be the subject of
cardiothoracic surgical debate regarding the timing and type of
surgical repair.
One novel approach to this entity includes the use of a ven-
tricular assist device (VAD) for cardiac support, circulatory sta-
bility, and maintenance of end-organ perfusion. The role of the
VAD may be as an adjunct to an attempted repair. In this scenario,
the postinfarct VSD is repaired, coronary bypass grafting is per-
formed, and the VAD is placed for ventricular unloading and
maintenance of adequate cardiac output. The use of implantable
VADs for this condition was described by Faber and colleagues3
with the HeartMate (Thoratec Laboratories, Pleasanton, Calif) and
Novacor (WorldHeart Corp, Ottawa, Ontario, Canada) systems.
Another scenario, however, is to place the VAD without attempt-
ing an initial repair. The rationale behind this approach is to avoid
operating on fresh infarct and to establish prompt circulatory
control. The BVS 5000 VAD has the advantage that it can be
placed with or without cardiopulmonary bypass. In addition, in-
flow to the VAD can be easily accomplished at the atrial level.
This is an ideal cannulation strategy for a VSD, in which it is
important to avoid a shunt at the ventricular level. As demonstrated
in our case, mechanical cardiac support was successful in restoring
hemodynamic stability and reversal of multiorgan system failure.
In conclusion, the postinfarction VSD may be managed in a
variety of ways. This case demonstrates the novel use of the BVS
5000 VAD with biatrial cannulation for the uncorrected postin-
farction VSD as a bridge to transplantation.
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Urgent inferior vena cava replacement with an autologous pericardium
tube graft
B-Khanh Lam, MD,a Gosta B. Pettersson, MD,a and David P. Vogt, MD,b Cleveland, Ohio
Surgical interventions involving the suprarenal inferiorvena cava (IVC) are uncommon. They are usually re-quired after the partial or complete resection of the IVCfor the management of malignant and nonmalignant dis-
eases.1,2 Three surgical techniques have been reported: patch angio-
plasty,3 replacement with spiral saphenous vein graft,1 and replace-
ment with extended polytetrafluoroethylene (ePTFE) grafts.1,2,4 We
report on an emergency case in which the accidentally transected
suprarenal IVC was replaced with an autologous pericardial tube.
Clinical Summary
A 42-year-old male man had right-sided flank pain and elevated
liver enzymes. Abdominal ultrasonography and computed tomo-
graphic scan demonstrated a 5-cm right renal mass (renal cell
carcinoma). Results of the metastatic workup were negative, and
the patient underwent a laparoscopic right radical nephrectomy.
The laparoscopic dissection of the renal tumor was difficult and
eventually complicated by severe bleeding, which could not be
controlled laparoscopically. The abdomen was opened, and by
manual tamponade of the undersurface of the liver and infusion of
blood and intravenous fluids, blood pressure could be maintained.
The cardiothoracic surgical team was consulted. A standard
median sternotomy was performed and extended to the laparot-
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omy. The patient was placed on cardiopulmonary bypass (CPB) by
cannulation of the aorta, superior vena cava, right atrium, and right
femoral vein. Transesophageal echocardiography and aortic vent-
ing were used to detect and prevent air embolism in case of a
patent foramen ovale. The liver was mobilized by releasing the
falciform and right triangular ligaments. This provided excellent
visualization of the proximal IVC, transected at the level of the
undersurface of the liver. The stapled distal IVC had retracted
inferiorly.
A 3  5-inch rectangular piece of autologous pericardium was
harvested for the reconstruction. The proximal pericardiocaval
anastomosis was circumferentially constructed with a running 5-0
Prolene suture (Ethicon, Inc, Somerville, NJ). The retracted distal
IVC was then clamped above the renal veins, and the staple lines
were resected. The distal pericardiocaval anastomosis was con-
structed with a 5-0 Prolene suture (Figure 1). The autologous
pericardial tube was finally closed longitudinally with a 5-0 Pro-
lene suture, creating a segment of neo-IVC. The IVC was un-
clamped, and flow was reestablished. The diameter of the neo-IVC
was at least 2 cm at its narrowest point. The patient was weaned
from CPB without difficulty.
After the operation, the patient required 4 weeks of hemodial-
ysis for acute renal failure. Results of lower extremity Doppler
examination were negative for deep vein thrombosis and venous
congestion. The patient was discharged with a regimen of warfarin
sodium and is doing well clinically 6 months after surgery. The
patient declined follow-up imaging.
Discussion
Transection of the IVC during laparoscopic nephrectomy was a
true nightmare, but instant laparotomy and compression provided
time to establish CPB. Normothermic CPB was used. The right
atrial and femoral vein cannulation, combined with vacuum-as-
sisted venous drainage, eliminated the need for deep hypothermia
and circulatory arrest. TEE and aortic venting were used to detect
and prevent air embolism. Mobilization of the liver provided
exposure, and vacuum-assisted venous atrial drainage provided a
bloodless field. End-to-end reanastomosis of the cava was not
possible. It turned out to be technically simple and quick to create
an IVC tube from a rectangular pericardial patch. Sewing to the
intrahepatically retracted and fragile proximal end of the cava was
possible because of good exposure and compliant tissue.
Various materials (xenopericardium, hepatic vein, omentum, peri-
toneofascia, ePTFE) have been used to reconstruct or replace the IVC.
Autologous pericardium was our choice in this urgent situation. It is
nonallogenic, biologic in origin, malleable, expandable under venous
pressure, hemostatic, durable, readily available, and free. In addition,
morphologic, immunohistologic, and fibrinolytic features of the au-
tologous pericardium make it a well-suited replacement for the IVC.
In their study, Iha and colleagues5 observed that autologous pericar-
dium differed significantly from other biologic (porcine, equine, and
bovine pericardium) and synthetic (ePTFE) grafts. Their animal data
showed that autologous pericardium had less endothelial lining
contraction and subendothelial fibrosis, along with better fibrino-
lytic activity. This has led us to believe that an endothelialized
autologous pericardial tube graft would be well suited to the
low-flow system of the IVC because of its low thrombogenicity
and low risk of contracture and narrowing.
Patch angioplasty with autologous pericardium was originally
described in patients with Budd-Chiari syndrome.3 When replace-
ment of the IVC was required, however, ePTFE tube grafts were
more commonly used.1,2 These grafts were patent up to 5 years.1
Our main concern relating to the choice of ePTFE was immediate
hemostasis. Spiral saphenous vein grafts are not commonly used
for IVC replacement and are time consuming, and early patency
rates have been poor.1 The approach described here (management
of CPB and use of autologous pericardium for the reconstruction)
has also been successfully used for elective renal tumor resection
with IVC tumor thrombus.
Figure 1. Photograph depicting construction of distal pericardiocaval anastomosis. Proximal anastomosis of
pericardial tube graft to intrahepatic IVC has been completed (arrow).
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